VEGFA and retinopathy of prematurity: Even though treatments like retinal photocoagulation and intravitreal therapy of anti-vascular endothelial growth factor (VEGF) agents can be timely applied for ROP, persistent sequelae and controversies still remains 3 due to the limited understanding of ROP pathogenesis and regulations.